Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON50600
NL-OMON50600
Completed
Not Applicable

Reducing renal function deterioration by means of increasing medication adherence, improving immunosuppressive drug exposure and supporting a healthy lifestyle - an implementation study. - RRFD

eids Universitair Medisch Centrum0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
eids Universitair Medisch Centrum
Enrollment
100
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- \> 1 year after kidney transplantation
  • •\- Follow\-up visits take place in LUMC
  • •\- Creatinine clearance (CKD\-EPI \> 25 ml/min)
  • •\- Immunosuppressive regimen based on tacrolimus
  • •\- Sufficient mastery of Dutch
  • •\- Access to and capacity to use the internet.
  • •\- Availability of a Smart\-phone (necessary for blistering)
  • •\- Informed consent

Exclusion Criteria

  • •\- No internet access
  • •\- Creatinine clearance (CKD\-EPI \* 25 ml/min)
  • •\- Insufficient knowledge of Dutch language
  • •\- Proven allergy for iodine contrast

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Reducing renal function deterioration by means of increasing medication adherence, improving immunosuppressive drug exposure and supporting a healthy lifestyle - an implementation studyRenal transplantationImmunosuppressantsMedication adherencee-HealthPatient participation
NL-OMON20914eiden University Medical Center, Leiden, The Netherlands100
Not yet recruiting
Not Applicable
Study of renal function renal protective effect of cooling method in laparoscopic partial nephrectomyRenal cell cacinoma
JPRN-UMIN000013867Kansai Medical University30
Recruiting
Not Applicable
Elucidation of renal function protection with human atrial natriuretic peptide (hANP)ischemic heart disease
JPRN-UMIN000010970Department of anesthesiology, Faculty of medicine,Kagawa university30
Completed
Phase 4
The prevention effect in renal disease patients taking a oral steroid with the rebamipide or the rabeprazole- a randomized control studyRenal disease
JPRN-UMIN000001611Graduate School of Medicine Science, Kumamoto University50
Completed
Not Applicable
The investigation of the renal protective effect of Carperitide(hANP:human atrial natriuretic peptide) during adult living donor renal transplantation, a single center experience.living donor renal transplantation
JPRN-UMIN000014279Toho University School of Medicine, Department of Anesthesiology30